Abstract
The vast majority of infectious agents enter the body through the mucosal surfaces, such as those of the lung and intestine. These surfaces are covered by an epithelium that forms the interface between the external environment and the internal milieu. The epithelium is an essential physical barrier between the potentially hostile outside world and the host, but is also actively involved in processes like infection, inflammation, and immunity. The epithelium is therefore considered an important component of the host defense system. Epithelial layers are frequently injured because they are exposed to environmental toxic agents such as chemicals and micro-organisms, and to mechanical injury. To prevent invasion of the underlying tissue by pathogens and toxic agents, this epithelial injury must be followed by a rapid repair response. This chapter focuses on the interplay between this epithelial repair and the host defense system at the epithelial surface, two mechanisms that appear to act in concert to protect the host from infection. Whereas many of the principle mechanisms that operate in the diverse epithelia display marked similarities, some characteristics are typical for one type of epithelium. This chapter focuses on the pulmonary epithelium.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Corrin, B. (2000) Normal lung structure, In Pathology of the lungs (Corrin, B., ed), Churchill Livingstone, London, pp. 1–34.
Danel, C. J. (1996) Morphological characteristics of human airway structures: diversity and unity, in Environmental impact on the airways. From injury to repair (Chretien, J. and Dusser, D., eds), Marcel Dekker, New York, pp. 19–42.
Crapo, J. D., Barry, B. E., Gehr, P., Bachofen, M. and Weibel, E. R. (1982) Cell number and cell characteristics of the normal human lung. Am. Rev. Resp. Dis. 126:332–337.
Bals, R. and Hiemstra, P. S. (2004) Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur. Respir. J. 23:327–333.
Ganz, T. (2004) Antimicrobial polypeptides. J. Leukoc. Biol. 75:34–38.
Message, S. D. and Johnston, S. L. (2004) Host defense function of the airway epithelium in health and disease: clinical background. J. Leukoc. Biol. 75:5–17.
Takeda, K., Kaisho, T. and Akira, S. (2003) Toll-like receptors. Annu. Rev. Immunol. 21: 335–376.
Poltorak, A., He, X., Smirnova, I., andet al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085–2088.
Agnese, D. M., Calvano, J. E., Hahm, S. J., andet al. (2002) Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 186: 1522–1525.
Wanner, A., Salathe, M. and O’Riordan, T. G. (1996) Mucociliary clearance in the airways. Am. J. Respir. Crit Care Med. 154:1868–1902.
Sleigh, M. A., Blake, J. R. and Liron, N. (1988) The propulsion of mucus by cilia. Am. Rev. Respir. Dis. 137:726–741.
Boucher, R. C. (2004) New concepts of the pathogenesis of cystic fibrosis lung disease. Eur. Respir. J 23:146–158.
Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389–395.
Sallenave, J. M. (2000) The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. Respir. Res. 1:87–92.
Ganz, T. (2003) Defensins: Antimicrobial peptides of innate immunity. Nature Rev. Immunol. 3: 710–720.
Schutte, B. C. and McCray, P. B., Jr. (2002) [beta]-defensins in lung host defense. Annu. Rev. Physiol 64:709–748.
Schutte, B. C., Mitros, J. P., Bartlett, J. A.,et al. (2002) Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc. Natl. Acad. Sci. U. S. A 99:2129–2133.
Kao, C. Y., Chen, Y., Zhao, Y. H. and Wu, R. (2003) ORFeome-Based Search of Airway Epithelial Cell-Specific Novel Human β-Defensin Genes. Am. J. Resp. Cell Mol. Biol. 29:71–80.
Moser, C., Weiner, D. J., Lysenko, E., Bals, R., Weiser, J. N. and Wilson, J. M. (2002) beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect. Immun. 70:3068–3072.
Zanetti, M. (2004) Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75:39–48.
Bals, R., Weiner, D. J., Meegalla, R. L. and Wilson, J. M. (1999) Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J. Clin. Invest 103:1113–1117.
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J.,et al. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454–457.
Hertz, C. J., Wu, Q., Porter, E. M.,et al. (2003) Activation of toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J. Immunol. 171:6820–6826.
Liu, L., Roberts, A. A. and Ganz, T. (2003) By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J. Immunol. 170:575–580.
Tsutsumi-Ishii, Y. and Nagaoka, I. (2003) Modulation of human beta-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production. J. Immunol. 170:4226–4236.
Akinbi, H. T., Epaud, R., Bhatt, H. and Weaver, T. E. (2000) Bacterial killing is enhanced by expression of lysozyme in the lungs of transgenic mice. J. Immunol. 165:5760–5766.
Singh, P. K., Parsek, M. R., Greenberg, E. P. and Welsh, M. J. (2002) A component of innate immunity prevents bacterial biofilm development. Nature 417:552–555.
Costerton, J. W., Stewart, P. S. and Greenberg, E. P. (1999) Bacterial Biofilms: A Common Cause of Persistent Infections. Science 284:1318.
Hiemstra, P. S., Maassen, R. J., Stolk, J., Heinzel-Wieland, R., Steffens, G. J. and Dijkman, J. H. (1996) Antibacterial activity of antileukoprotease. Infect. Immun. 64:4520–4524.
McNeely, T. B., Dealy, M., Dripps, D. J., Orenstein, J. M., Eisenberg, S. P. and Wahl, S. M. (1995) Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J. Clin. Invest. 96:456–464.
Simpson, A. J., Maxwell, A. I., Govan, J. R., Haslett, C. and Sallenave, J. M. (1999) Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett. 452:309–313.
Cole, A. M., Liao, H. I., Stuchlik, O., Tilan, J., Pohl, J. and Ganz, T. (2002) Cationic Polypeptides Are Required for Antibacterial Activity of Human Airway Fluid. J. Immunol. 169:6985.
Nakamura, A., Mori, Y., Hagiwara, K., et al. (2003) Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice. J. Exp. Med. 197:669–674.
Simpson, A. J., Wallace, W. A., Marsden, M. E., et al. (2001) Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection. J. Immunol. 167: 1778–1786.
Yang, D., Chertov, O. and Oppenheim, J. J. (2001) Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J. Leukoc. Biol. 69:691–697.
Davidson, D. J., Currie, A. J., Reid, G. S. D., et al. (2004) The Cationic Antimicrobial Peptide LL-37 Modulates Dendritic Cell Differentiation and Dendritic Cell-Induced T Cell Polarization. J. Immunol. 172: 1146–1156.
Lillard, J. W., Jr., Boyaka, P. N., Chertov, O., Oppenheim, J. J. and McGhee, J. R. (1999) Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. Proc. Natl. Acad. Sci. U. S. A 96: 651–656.
Erjefalt, J. S. and Persson, C. G. A. (1997) Airway epithelial repair: breathtakingly quick and multipotentially pathogenic. Thorax 52:1010–1012.
Puchelle, E. and Zahm, J.-M. (1996) Repair processes of the airway epithelium, in Environmental impact on the airways. From injury to repair. (Chretien, J. and Dusser, D., eds), Marcel Dekker, New York, pp. 157–182.
Rennard, S. I. (1996) Repair mechanisms in asthma. J. Allergy Clin. Immunol 98:S278–S286.
Jacinto, A., Martinez-Arias, A. and Martin, P. (2001) Mechanisms of epithelial fusion and repair. Nature Cell Biology 3:E117–E123.
Keenan, K. P., Combs, J. W. and McDowell, E. M. (1982) Regeneration of hamster tracheal epithelium after mechanical injury. I. Focal lesions: quantitative morphologic study of cell proliferation. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 41:193–214.
Erjefalt, J. S., Erjefalt, I., Sundler, F. and Persson, C. G. (1995) In vivo restitution of airway epithelium. Cell Tissue Res. 281:305–316.
Zahm, J. M., Kaplan, H., Herard, A. L.,et al. (1997) Cell migration and proliferation during the in vitro wound repair of the respiratory epithelium. Cell Motil. Cytoskeleton 37:33–43.
Puchelle, E. and Peault, B. (2000) Human airway xenograft models of epithelial cell regeneration. Resp.Res. 1:125–128.
Murphy, C. J., Foster, B. A., Mannis, M. J., Selsted, M. E. and Reid, T. W. (1993) Defensins are mitogenic for epithelial cells and fibroblasts. J. Cell. Physiol. 155:408–413.
Aarbiou, J., Ertmann, M., van Wetering, S.,et al. (2002) Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J. Leukoc. Biol. 72:167–174.
Calafat, J., Janssen, H., Stahle-Backdahl, M., Zuurbier, A. E., Knol, E. F. and Egesten, A. (1997) Human monocytes and neutrophils store transforming growth factor-alpha in a subpopulation of cytoplasmic granules. Blood 90:1255–1266.
Egesten, A., Calafat, J., Knol, E. F., Janssen, H. and Walz, T. M. (1996) Subcellular localization of transforming growth factor-alpha in human eosinophil granulocytes. Blood 87:3910–3918.
Takeyama, K., Jung, B., Shim, J. J.,et al. (2001) Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am. J. Physiol. Lung Cell Mol. Physiol. 280: L165–L172.
Takeyama, K., Dabbagh, K., Jeong, S. J.,et al. (2000) Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J. Immunol. 164:1546–1552.
Breuer, R., Christensen, T. G., Lucey, E. C., Stone, P. J. and Snider, G. L. (1987) An ultrastructural morphometric analysis of elastase-treated hamster bronchi shows discharge followed by progressive accumulation of secretory granules. Am. Rev. Respir. Dis. 136:698–703.
Stolk, J., Rudolphus, A., Davies, P.,et al. (1992) Introduction of emphysema and bronchial mucus cell hyperplasia by intratracheal instillation of lipopolysaccharide in the hamster. J. Pathol. 167: 349–356.
Frohm, M., Gunne, H., Bergman, A.-C.,et al. (1996) Biochemical and antibacterial analysis of human wound and blister fluid. Eur. J. Biochem. 237:86–92.
Dorschner, R. A., Pestonjamasp, V. K., Tamakuwala, S.,et al. (2001) Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Invest. Dermatol. 117: 91–97.
Heilborn, J. D., Nilsson, M. F., Kratz, G.,et al. (2003) The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120:379–389.
Schmid, P., Grenet, O., Medina, J., Chibout, S. D., Osborne, C. and Cox, D. A. (2001) An intrinsic antibiotic mechanism in wounds and tissue-engineered skin. J. Invest. Dermatol. 116:471–472.
Wingens, M., van Bergen, B. H., Hiemstra, P. S.,et al. (1998) Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes. J. Invest. Dermatol. 111:996–1002.
van Bergen, B. H., Andriessen, M. P., Spruijt, K. I., van de Kerkhof, P. C. and Schalkwijk, J. (1996) Expression of SKALP/elafin during wound healing in human skin. Arch. Dermatol. Res. 288:458–462.
Frohm, M., Agerberth, B., Ahangari, G.,et al. (1997) The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272: 15258–15263.
Harder, J., Bartels, J., Christophers, E. and Schröder, J.-M. (1997) A peptide antibiotic from human skin. Nature 387:861.
Harder, J., Bartels, J., Christophers, E. and Schroder, J. M. (2001) Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:5707–5713.
Sorensen, O. E., Cowland, J. B., Theilgaard-Monch, K., Liu, L., Ganz, T. and Borregaard, N. (2003) Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J. Immunol. 170:5583–5589.
Aarbiou, J., Verhoosel, R. M., van Wetering, S.,et al. (2004) Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. Am. J. Respir. Cell Mol. Biol. 30:193–201.
Hagiwara, T., Shinoda, I., Fukuwatari, Y. and Shimamura, S. (1995) Effects of lactoferrin and its peptides on proliferation of rat intestinal epithelial cell line, IEC-18, in the presence of epidermal growth factor. Biosci. Biotechnol. Biochem. 59:1875–1881.
Aarbiou, J., Van Schadewijk, A., Stolk, J.,et al. (2004) Human neutrophil defensins and secretory leukocyte proteinase inhibitor in squamous metaplastic epithelium of bronchial airways. Inflamm. Res. 53: 230–238.
Koczulla, R., von Degenfeld, G., Kupatt, C., Krotz, F., Zahler, S., Gloe, T., Issbrucker, K., Unterberger, P., Zaiou, M., Lebherz, C., Karl, A., Raake, P., Pfosser, A., Boekstegers, P., Welsch, U., Hiemstra, P. S., Vogelmeier, C., Gallo, R. L., Clauss, M. and Bals, R. (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111, 1665–1672.
Tjabringa, G. S., Aarbiou, J., Ninaber, D. K.,et al. (2003) The Antimicrobial Peptide LL-37 Activates Innate Immunity at the Airway Epithelial Surface by Transactivation of the Epidermal Growth Factor Receptor. J. Immunol. 171:6690–6696.
Frye, M., Bargon, J. and Gropp, R. (2001) Expression of human beta-defensin-1 promotes differentiation of keratinocytes. J Mol. Med. 79:275–282.
Ashcroft, G. S., Lei, K., Jin, W.,et al. (2000) Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat. Med. 6:1147–1153.
Zhang, D., Simmen, R. C., Michel, F. J., Zhao, G., Vale-Cruz, D. and Simmen, F. A. (2002) Secretory leukocyte protease inhibitor mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growth-associated genes. J. Biol. Chem. 277:29,999–30,009.
Zhu, J., Nathan, C., Jin, W.,et al. (2002) Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 111:867–878.
Kikuchi, T., Abe, T., Yaekashiwa, M., et al. (2000) Secretory leukoprotease inhibitor augments hepatocyte growth factor production in human lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 23:364–370.
Zahm, J. M., Debordeaux, C., Raby, B., Klossek, J. M., Bonnet, N. and Puchelle, E. (2000) Motogenic effect of recombinant HGF on airway epithelial cells during the in vitro wound repair of the respiratory epithelium. J. Cell. Physiol. 185:447–453.
Mogi, M., Inagaki, H., Kojima, K., Minami, M. and Harada, M. (1995) Transforming growth factor-alpha in human submandibular gland and saliva. J. Immunoassay 16:379–394.
Murakami, M., Ohtake, T., Dorschner, R. A. and Gallo, R. L. (2002) Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J Dent. Res. 81:845–850.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Hiemstra, P.S. (2005). Repair and Defense Systems at the Epithelial Surface in the Lung. In: Walz, W. (eds) Integrative Physiology in the Proteomics and Post-Genomics Age. Humana Press. https://doi.org/10.1385/1-59259-925-7:201
Download citation
DOI: https://doi.org/10.1385/1-59259-925-7:201
Publisher Name: Humana Press
Print ISBN: 978-1-58829-315-2
Online ISBN: 978-1-59259-925-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)